Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
Fundamentals
Mkt Cap
$1.12B
Volume
-
52W High
$29.65
52W Low
$12.26
PE Ratio
-17.39
Avg. Volume
2.12M
EPS (Annual)
-$3.04
P/B
8.59
Rev/Employee
$406,140.00
Earnings
Nov 05
25
Bearish Sentiment
How do you feel about TNDM?
deepthinker
$TNDM The day Sheridan joined in 2019, the stock was $69. It’s down 77.5% since then. In inflation adjusted terms, it’s probably 90%. And, he’s 71 years old!
deepthinker
$TNDM So, $BBNX has a market cap of $1.3 billion or so. Tandem is $1.2 billion. Tandem can’t be sold without Dexcom permission, and they can’t grow much because they don’t have a true patch pump.
deepthinker
$TNDM Will patients be convinced that Mobi tubeless is really a patch pump (when it’s actually not).